NautaDutilh has advised ATAI Life Sciences N.V. on its registered underwritten offering, which generated gross proceeds of approximately USD 130 million. The shares were sold at a price of USD 5.48 per share. Jefferies LLC acted as lead bookrunner, Berenberg Capital Markets LLC as passive bookrunner, and Oppenheimer & Co. Inc. and Canaccord Genuity LLC as co-managers for the offering.
“We are glad to have represented ATAI on another significant transaction and are looking forward to continuing working with the excellent team at ATAI in their journey of transforming the treatment of mental health disorders.”
The NautaDutilh team included, Paul van der Bijl, Nina Kielman, Marije Bader, Niels van Ham, Joppe Schoute, Esther Schreiber and Lentle Nijs.